Cartesian Therapeutics (RNAC) Other Gross PP&E Adjustments: 2015-2025
Historic Other Gross PP&E Adjustments for Cartesian Therapeutics (RNAC) over the last 10 years, with Sep 2025 value amounting to $11.5 million.
- Cartesian Therapeutics' Other Gross PP&E Adjustments rose 282.95% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.6 million, marking a year-over-year increase of 2200.41%. This contributed to the annual value of $5.7 million for FY2024, which is 353.42% up from last year.
- Latest data reveals that Cartesian Therapeutics reported Other Gross PP&E Adjustments of $11.5 million as of Q3 2025, which was up 8.50% from $10.6 million recorded in Q2 2025.
- In the past 5 years, Cartesian Therapeutics' Other Gross PP&E Adjustments registered a high of $11.5 million during Q3 2025, and its lowest value of -$6.8 million during Q4 2021.
- Its 3-year average for Other Gross PP&E Adjustments is $2.4 million, with a median of -$1.2 million in 2024.
- As far as peak fluctuations go, Cartesian Therapeutics' Other Gross PP&E Adjustments tumbled by 104.48% in 2023, and later surged by 1,024.50% in 2025.
- Over the past 5 years, Cartesian Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at -$6.8 million in 2021, then spiked by 84.03% to -$1.1 million in 2022, then crashed by 104.48% to -$2.2 million in 2023, then soared by 353.42% to $5.7 million in 2024, then spiked by 282.95% to $11.5 million in 2025.
- Its last three reported values are $11.5 million in Q3 2025, $10.6 million for Q2 2025, and $7.8 million during Q1 2025.